MedPath

云南司艾特药业有限公司

Ownership
-
Established
2003-06-26
Employees
-
Market Cap
-
Website

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

15

NMPA:15

Drug Approvals

Glucose and Sodium Chloride Injection

Product Name
葡萄糖氯化钠注射液
Approval Number
国药准字H20103753
Approval Date
Nov 25, 2020
NMPA

Glucose Injection

Product Name
葡萄糖注射液
Approval Number
国药准字H20103750
Approval Date
Nov 25, 2020
NMPA

Metronidazole and Sodium Chloride Injection

Product Name
甲硝唑氯化钠注射液
Approval Number
国药准字H20103744
Approval Date
Nov 25, 2020
NMPA

Glucose and Sodium Chloride Injection

Product Name
葡萄糖氯化钠注射液
Approval Number
国药准字H20103752
Approval Date
Nov 25, 2020
NMPA

Glucose Injection

Product Name
葡萄糖注射液
Approval Number
国药准字H20103751
Approval Date
Nov 25, 2020
NMPA

Glucose Injection

Product Name
葡萄糖注射液
Approval Number
国药准字H20103748
Approval Date
Nov 25, 2020
NMPA

Glucose and Sodium Chloride Injection

Product Name
葡萄糖氯化钠注射液
Approval Number
国药准字H20103754
Approval Date
Nov 25, 2020
NMPA

Glucose Injection

Product Name
葡萄糖注射液
Approval Number
国药准字H20103746
Approval Date
Nov 25, 2020
NMPA

Glucose Injection

Product Name
葡萄糖注射液
Approval Number
国药准字H20103747
Approval Date
Nov 25, 2020
NMPA

Metronidazole and Sodium Chloride Injection

Product Name
甲硝唑氯化钠注射液
Approval Number
国药准字H20103743
Approval Date
Nov 25, 2020
NMPA
  • Prev
  • 1
  • 2
  • Next

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.